A Comparison of Two Dose Levels of Indinavir Combined With Two Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTIs) in HIV-Infected Patients
NCT00002406 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 350
Last updated 2005-06-24
Summary
The purpose of this study is to determine if two dose levels of indinavir combined with two nucleoside analogue reverse transcriptase inhibitors (NRTIs) have the same effect on plasma viral load (level of HIV in the blood).
Conditions
- HIV Infections
Interventions
- DRUG
-
Indinavir sulfate
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Purpose
- TREATMENT
- Masking
- NONE
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
A Comparison of 141W94 and Indinavir in HIV-Infected Patients
NCT00002202 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Indinavir Plus Ritonavir Plus Two NRTIs vs. Nelfinavir Plus Two NRTIs in HIV Positive Patients (0639-112)(COMPLETED)
NCT00541463 ·Status: COMPLETED ·Phase: PHASE2
-
A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TC
NCT00002208 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or Saquinavir
NCT00001133 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of 1592U89 in Combination With Protease Inhibitors in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
NCT00002440 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Three Different Anti-HIV Drug Combinations in HIV-Infected Patients
NCT00002410 ·Status: COMPLETED ·Phase: PHASE3
-
A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease Inhibitors
NCT00002235 ·Status: COMPLETED ·Phase: PHASE2
-
A Study on the Safety and Effectiveness of L-756423 Plus Indinavir in HIV-Positive Patients Who Have Previously Taken Indinavir
NCT00002452 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Compare the Safety and Effectiveness of Indinavir Combined With Stavudine and Lamivudine
NCT00002424 ·Status: SUSPENDED ·Phase: PHASE2
-
Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With Nelfinavir
NCT00002220 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients
NCT00002168 ·Status: COMPLETED ·Phase: NA
-
A Study of Three Drug Combination Therapies in HIV-Infected Patients Who Have Never Been Treated With Anti-HIV Drugs
NCT00002407 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
NCT00002451 ·Status: UNKNOWN ·Phase: PHASE2
-
The Safety and Effectiveness of Retrovir Plus HIVID Combined With Either Nevirapine or Invirase in the Treatment of HIV Infection
NCT00002347 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks
NCT00000914 ·Status: COMPLETED ·Phase: NA
-
A Study to Compare Two Different Anti-HIV Drug Regimens
NCT00000924 ·Status: COMPLETED ·Phase: PHASE2
-
A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients
NCT00000912 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Effectiveness of Indinavir Sulfate Plus Efavirenz
NCT00002387 ·Status: COMPLETED ·Phase: NA
-
A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV Drugs
NCT00002411 ·Status: COMPLETED ·Phase: NA
-
A Study of Indinavir Sulfate Given Together With Stavudine to HIV-Positive Patients
NCT00002354 ·Status: COMPLETED ·Phase: NA
-
A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects
NCT00363142 ·Status: COMPLETED ·Phase: PHASE3
-
Dose Ranging Study of GSK1265744 Plus Nucleoside Reverse Transcriptase Inhibitors for Induction of Human Immunodeficiency Virus-1 (HIV-1) Virologic Suppression Followed by Virologic Suppression Maintenance by GSK1265744 Plus Rilpivirine
NCT01641809 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients With No Symptoms of the Disease
NCT00001045 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV
NCT00082394 ·Status: COMPLETED ·Phase: PHASE4
-
The Addition of Indinavir to Anti-HIV Treatment in HIV-Infected Patients
NCT00000861 ·Status: COMPLETED ·Phase: NA